The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AI Diagnostics Market Research Report 2025
Synopsis
As a subfield in artificial intelligence, diagnosis is concerned with the development of algorithms and techniques that are able to determine whether the behaviour of a system is correct.
The global AI Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Diagnostics.
Report Scope
The AI Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Oxitone Medical Ltd
MC10, Inc
Medtronic
UE LifeSciences
Vital Connect
Biomeme
MidMark Corp
Bio SB
Cerora
CellScope
Digital Diagnostics
Siemens Healthineers
Nanox
Roche
Segment by Type
Hardware
Software
Service
Segment by Application
Hospitals
Research Laboratories
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
As a subfield in artificial intelligence, diagnosis is concerned with the development of algorithms and techniques that are able to determine whether the behaviour of a system is correct.
The global AI Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Diagnostics.
Report Scope
The AI Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Oxitone Medical Ltd
MC10, Inc
Medtronic
UE LifeSciences
Vital Connect
Biomeme
MidMark Corp
Bio SB
Cerora
CellScope
Digital Diagnostics
Siemens Healthineers
Nanox
Roche
Segment by Type
Hardware
Software
Service
Segment by Application
Hospitals
Research Laboratories
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global AI Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Research Laboratories
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Diagnostics Market Perspective (2019-2030)
2.2 AI Diagnostics Growth Trends by Region
2.2.1 Global AI Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 AI Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 AI Diagnostics Market Dynamics
2.3.1 AI Diagnostics Industry Trends
2.3.2 AI Diagnostics Market Drivers
2.3.3 AI Diagnostics Market Challenges
2.3.4 AI Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Diagnostics Players by Revenue
3.1.1 Global Top AI Diagnostics Players by Revenue (2019-2024)
3.1.2 Global AI Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global AI Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Diagnostics Revenue
3.4 Global AI Diagnostics Market Concentration Ratio
3.4.1 Global AI Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Diagnostics Revenue in 2023
3.5 AI Diagnostics Key Players Head office and Area Served
3.6 Key Players AI Diagnostics Product Solution and Service
3.7 Date of Enter into AI Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Diagnostics Breakdown Data by Type
4.1 Global AI Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global AI Diagnostics Forecasted Market Size by Type (2025-2030)
5 AI Diagnostics Breakdown Data by Application
5.1 Global AI Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global AI Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI Diagnostics Market Size (2019-2030)
6.2 North America AI Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI Diagnostics Market Size by Country (2019-2024)
6.4 North America AI Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Diagnostics Market Size (2019-2030)
7.2 Europe AI Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI Diagnostics Market Size by Country (2019-2024)
7.4 Europe AI Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific AI Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific AI Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Diagnostics Market Size (2019-2030)
9.2 Latin America AI Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI Diagnostics Market Size by Country (2019-2024)
9.4 Latin America AI Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa AI Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa AI Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Oxitone Medical Ltd
11.1.1 Oxitone Medical Ltd Company Detail
11.1.2 Oxitone Medical Ltd Business Overview
11.1.3 Oxitone Medical Ltd AI Diagnostics Introduction
11.1.4 Oxitone Medical Ltd Revenue in AI Diagnostics Business (2019-2024)
11.1.5 Oxitone Medical Ltd Recent Development
11.2 MC10, Inc
11.2.1 MC10, Inc Company Detail
11.2.2 MC10, Inc Business Overview
11.2.3 MC10, Inc AI Diagnostics Introduction
11.2.4 MC10, Inc Revenue in AI Diagnostics Business (2019-2024)
11.2.5 MC10, Inc Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic AI Diagnostics Introduction
11.3.4 Medtronic Revenue in AI Diagnostics Business (2019-2024)
11.3.5 Medtronic Recent Development
11.4 UE LifeSciences
11.4.1 UE LifeSciences Company Detail
11.4.2 UE LifeSciences Business Overview
11.4.3 UE LifeSciences AI Diagnostics Introduction
11.4.4 UE LifeSciences Revenue in AI Diagnostics Business (2019-2024)
11.4.5 UE LifeSciences Recent Development
11.5 Vital Connect
11.5.1 Vital Connect Company Detail
11.5.2 Vital Connect Business Overview
11.5.3 Vital Connect AI Diagnostics Introduction
11.5.4 Vital Connect Revenue in AI Diagnostics Business (2019-2024)
11.5.5 Vital Connect Recent Development
11.6 Biomeme
11.6.1 Biomeme Company Detail
11.6.2 Biomeme Business Overview
11.6.3 Biomeme AI Diagnostics Introduction
11.6.4 Biomeme Revenue in AI Diagnostics Business (2019-2024)
11.6.5 Biomeme Recent Development
11.7 MidMark Corp
11.7.1 MidMark Corp Company Detail
11.7.2 MidMark Corp Business Overview
11.7.3 MidMark Corp AI Diagnostics Introduction
11.7.4 MidMark Corp Revenue in AI Diagnostics Business (2019-2024)
11.7.5 MidMark Corp Recent Development
11.8 Bio SB
11.8.1 Bio SB Company Detail
11.8.2 Bio SB Business Overview
11.8.3 Bio SB AI Diagnostics Introduction
11.8.4 Bio SB Revenue in AI Diagnostics Business (2019-2024)
11.8.5 Bio SB Recent Development
11.9 Cerora
11.9.1 Cerora Company Detail
11.9.2 Cerora Business Overview
11.9.3 Cerora AI Diagnostics Introduction
11.9.4 Cerora Revenue in AI Diagnostics Business (2019-2024)
11.9.5 Cerora Recent Development
11.10 CellScope
11.10.1 CellScope Company Detail
11.10.2 CellScope Business Overview
11.10.3 CellScope AI Diagnostics Introduction
11.10.4 CellScope Revenue in AI Diagnostics Business (2019-2024)
11.10.5 CellScope Recent Development
11.11 Digital Diagnostics
11.11.1 Digital Diagnostics Company Detail
11.11.2 Digital Diagnostics Business Overview
11.11.3 Digital Diagnostics AI Diagnostics Introduction
11.11.4 Digital Diagnostics Revenue in AI Diagnostics Business (2019-2024)
11.11.5 Digital Diagnostics Recent Development
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Detail
11.12.2 Siemens Healthineers Business Overview
11.12.3 Siemens Healthineers AI Diagnostics Introduction
11.12.4 Siemens Healthineers Revenue in AI Diagnostics Business (2019-2024)
11.12.5 Siemens Healthineers Recent Development
11.13 Nanox
11.13.1 Nanox Company Detail
11.13.2 Nanox Business Overview
11.13.3 Nanox AI Diagnostics Introduction
11.13.4 Nanox Revenue in AI Diagnostics Business (2019-2024)
11.13.5 Nanox Recent Development
11.14 Roche
11.14.1 Roche Company Detail
11.14.2 Roche Business Overview
11.14.3 Roche AI Diagnostics Introduction
11.14.4 Roche Revenue in AI Diagnostics Business (2019-2024)
11.14.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global AI Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hardware
Table 3. Key Players of Software
Table 4. Key Players of Service
Table 5. Global AI Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global AI Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global AI Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global AI Diagnostics Market Share by Region (2019-2024)
Table 9. Global AI Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global AI Diagnostics Market Share by Region (2025-2030)
Table 11. AI Diagnostics Market Trends
Table 12. AI Diagnostics Market Drivers
Table 13. AI Diagnostics Market Challenges
Table 14. AI Diagnostics Market Restraints
Table 15. Global AI Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global AI Diagnostics Market Share by Players (2019-2024)
Table 17. Global Top AI Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Diagnostics as of 2023)
Table 18. Ranking of Global Top AI Diagnostics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by AI Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players AI Diagnostics Product Solution and Service
Table 22. Date of Enter into AI Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global AI Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global AI Diagnostics Revenue Market Share by Type (2019-2024)
Table 26. Global AI Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global AI Diagnostics Revenue Market Share by Type (2025-2030)
Table 28. Global AI Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global AI Diagnostics Revenue Market Share by Application (2019-2024)
Table 30. Global AI Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global AI Diagnostics Revenue Market Share by Application (2025-2030)
Table 32. North America AI Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America AI Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America AI Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe AI Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe AI Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe AI Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific AI Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific AI Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific AI Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America AI Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America AI Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America AI Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa AI Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa AI Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa AI Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Oxitone Medical Ltd Company Detail
Table 48. Oxitone Medical Ltd Business Overview
Table 49. Oxitone Medical Ltd AI Diagnostics Product
Table 50. Oxitone Medical Ltd Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 51. Oxitone Medical Ltd Recent Development
Table 52. MC10, Inc Company Detail
Table 53. MC10, Inc Business Overview
Table 54. MC10, Inc AI Diagnostics Product
Table 55. MC10, Inc Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 56. MC10, Inc Recent Development
Table 57. Medtronic Company Detail
Table 58. Medtronic Business Overview
Table 59. Medtronic AI Diagnostics Product
Table 60. Medtronic Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 61. Medtronic Recent Development
Table 62. UE LifeSciences Company Detail
Table 63. UE LifeSciences Business Overview
Table 64. UE LifeSciences AI Diagnostics Product
Table 65. UE LifeSciences Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 66. UE LifeSciences Recent Development
Table 67. Vital Connect Company Detail
Table 68. Vital Connect Business Overview
Table 69. Vital Connect AI Diagnostics Product
Table 70. Vital Connect Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 71. Vital Connect Recent Development
Table 72. Biomeme Company Detail
Table 73. Biomeme Business Overview
Table 74. Biomeme AI Diagnostics Product
Table 75. Biomeme Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 76. Biomeme Recent Development
Table 77. MidMark Corp Company Detail
Table 78. MidMark Corp Business Overview
Table 79. MidMark Corp AI Diagnostics Product
Table 80. MidMark Corp Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 81. MidMark Corp Recent Development
Table 82. Bio SB Company Detail
Table 83. Bio SB Business Overview
Table 84. Bio SB AI Diagnostics Product
Table 85. Bio SB Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 86. Bio SB Recent Development
Table 87. Cerora Company Detail
Table 88. Cerora Business Overview
Table 89. Cerora AI Diagnostics Product
Table 90. Cerora Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 91. Cerora Recent Development
Table 92. CellScope Company Detail
Table 93. CellScope Business Overview
Table 94. CellScope AI Diagnostics Product
Table 95. CellScope Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 96. CellScope Recent Development
Table 97. Digital Diagnostics Company Detail
Table 98. Digital Diagnostics Business Overview
Table 99. Digital Diagnostics AI Diagnostics Product
Table 100. Digital Diagnostics Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 101. Digital Diagnostics Recent Development
Table 102. Siemens Healthineers Company Detail
Table 103. Siemens Healthineers Business Overview
Table 104. Siemens Healthineers AI Diagnostics Product
Table 105. Siemens Healthineers Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 106. Siemens Healthineers Recent Development
Table 107. Nanox Company Detail
Table 108. Nanox Business Overview
Table 109. Nanox AI Diagnostics Product
Table 110. Nanox Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 111. Nanox Recent Development
Table 112. Roche Company Detail
Table 113. Roche Business Overview
Table 114. Roche AI Diagnostics Product
Table 115. Roche Revenue in AI Diagnostics Business (2019-2024) & (US$ Million)
Table 116. Roche Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AI Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global AI Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Hardware Features
Figure 4. Software Features
Figure 5. Service Features
Figure 6. Global AI Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global AI Diagnostics Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Research Laboratories Case Studies
Figure 10. Contract Research Organizations Case Studies
Figure 11. Others Case Studies
Figure 12. AI Diagnostics Report Years Considered
Figure 13. Global AI Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global AI Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global AI Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global AI Diagnostics Market Share by Players in 2023
Figure 17. Global Top AI Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by AI Diagnostics Revenue in 2023
Figure 19. North America AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America AI Diagnostics Market Share by Country (2019-2030)
Figure 21. United States AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe AI Diagnostics Market Share by Country (2019-2030)
Figure 25. Germany AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific AI Diagnostics Market Share by Region (2019-2030)
Figure 33. China AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America AI Diagnostics Market Share by Country (2019-2030)
Figure 41. Mexico AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa AI Diagnostics Market Share by Country (2019-2030)
Figure 45. Turkey AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia AI Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Oxitone Medical Ltd Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 48. MC10, Inc Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 49. Medtronic Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 50. UE LifeSciences Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 51. Vital Connect Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 52. Biomeme Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 53. MidMark Corp Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 54. Bio SB Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 55. Cerora Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 56. CellScope Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 57. Digital Diagnostics Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 58. Siemens Healthineers Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 59. Nanox Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 60. Roche Revenue Growth Rate in AI Diagnostics Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
